Pentoxifylline Suppliers & Bulk Manufacturers
Available Forms: Tablets
Available Strengths: 400 mg
Reference Brands: Trental (USA/EU)
Category:
Heart Disorder
Pentoxifylline is available in Tablets
and strengths such as 400 mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Pentoxifylline is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Pentoxifylline can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Pentoxifylline is a xanthine derivative widely used in the management of peripheral vascular disease and other circulatory disorders. It acts as a phosphodiesterase inhibitor (PDEi), improving blood flow by reducing blood viscosity and enhancing red blood cell flexibility, thereby facilitating better microcirculation in ischemic tissues. By modulating blood rheology, pentoxifylline helps relieve symptoms of intermittent claudication and supports overall vascular health.
Pentoxifylline is administered orally, typically in tablet form, and is indicated for patients with peripheral artery disease, chronic occlusive arterial disease, or other conditions where improved blood flow can benefit tissue oxygenation. It has also been explored for off-label uses in vascular complications and microvascular disorders, though clinicians must carefully assess its suitability for individual patients.
Given its pharmacological complexity, pentoxifylline requires careful monitoring for adverse effects and potential drug interactions. Common side effects include gastrointestinal disturbances, dizziness, and headache, while severe reactions are rare. Its pharmacokinetics, dosing regimen, and patient-specific factors must be considered to ensure safety and efficacy. Pentoxifylline remains an important therapeutic option in cardiovascular care, offering targeted improvement of circulation and support for patients with vascular insufficiency.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing